🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro KwikPen vs vial — looking for input Page 7

Mounjaro KwikPen vs vial — looking for input

tony_orlando Sat, Oct 19, 2024 at 1:14 AM 33 replies 2,392 viewsPage 7 of 7
sarah_nash92
Member
712
3,123
Jun 2024
Nashville, TN
Nov 14, 2024 at 12:37 PM#31
tony_orlando said:
Nothing dramatic to report, which is the report.

This is where I part company with the consensus forming above. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Nov 14, 2024 at 6:37 PM
2 0NauseaFreeNow, SteveThurs
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Nov 16, 2024 at 10:04 AM#32
tony_orlando said:
Nothing dramatic to report, which is the report.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

Correct me if the detail matters more than I have assumed.

3 1mike.trainer_LA, sarah_nash92, FitDadDave
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Nov 18, 2024 at 7:32 AM#33
tony_orlando said:
Nothing dramatic to report, which is the report.

Genuinely useful, thank you. I had the facts and not the framework.

4 2mike_nyc, VendorMark, COA_Karl and 1 other
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Nov 20, 2024 at 5:01 AM#34

Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Last edited: Nov 20, 2024 at 11:01 AM
5 3SarahChen_PharmD, sarah.morrison, NeuroNate and 2 others
Reply Quote Save Share Report
MikeNYC_runner
Member
378
1,678
Jul 2024
New York, NY
Nov 22, 2024 at 2:31 AM#35
pete_nash said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Can confirm. Same sequence, different timescale.

6 4MASHdoc_SA, GenomicsKate, Dr.ObesityMed and 3 others
Reply Quote Save Share Report
1567

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register